Royal Marsden NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Completed
- Conditions
- Non-Hodgkins Lymphoma
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 39
- Registration Number
- NCT00301301
- Locations
- π¬π§
Royal Marsden NHS trust, Sutton, Surrey, United Kingdom
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).
Completed
- Conditions
- Non-Hodgkins Lymphoma
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 152
- Registration Number
- NCT00301288
- Locations
- π¬π§
Royal Marsden NHS trust, Sutton, Surrey, United Kingdom
Assessing Free Immunoglobulin Light Chains in Patients With Myeloma
Completed
- Conditions
- Multiple Myeloma
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2006-03-10
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Registration Number
- NCT00301275
- Locations
- π¬π§
Royal Marsden NHS trust, Sutton, Surrey, United Kingdom
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.
Phase 2
Completed
- Conditions
- Multiple MyelomaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2006-10-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 150
- Registration Number
- NCT00300664
Modelling Internal Hepatic Movement With an External Abdominal Marker
- Conditions
- Patients With Liver Metastases From Colorectal Cancer
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT00299299
- Locations
- π¬π§
Royal Marsden Hospital, Chelsea, United Kingdom
A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.
Phase 2
- Conditions
- Peripheral T Cell Lymphoma (PTCL)
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2006-03-06
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 8
- Registration Number
- NCT00299351
Dual Time Point PET Imaging in Lymphoma
- Conditions
- Hodgkin's or Non-Hodgkin's Lymphoma
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2006-10-11
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Registration Number
- NCT00297557
A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion
Phase 2
Completed
- Conditions
- Chronic Lymphocytic Leukaemia
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Registration Number
- NCT00292760
Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 44
- Registration Number
- NCT00260364
- Locations
- π¬π§
The Royal Marsden Foundation Hospital NHS Trust, London and Surrey, London, United Kingdom
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2010-01-06
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 172
- Registration Number
- NCT00220116
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath